Literature DB >> 3360895

Free insulin-like growth factor I (IGF-I) and IGF-II in human saliva.

D C Costigan1, H J Guyda, B I Posner.   

Abstract

We found that human saliva contains both insulin-like growth factor I (IGF-I) and IGF-II but no significant binding proteins, and that salivary IGF-I levels correlated with plasma GH levels. Mixed saliva had globular proteins precipitated by freezing/thawing. After centrifugation the clear supernatant was used directly in the IGF-I RIA (Van Wyk and Underwood antibody) and in a human placental membrane RRA for IGF-II. The lower limits of detection for IGF-I and IGF-II were 0.7 ng/mL (micrograms/L) and 1.2 ng/mL (micrograms/L), respectively. Iodinated IGF added to saliva was not degraded, as assessed by trichloroacetic acid precipitability and placental membrane binding. In saliva from 14 normal subjects, IGF-I was measurable in all. IGF-II was detectable only in 8 of 14 subjects; the mean value in these 8 subjects was 2.6 +/- 0.6 (+/- SE) ng/mL (micrograms/L). The mol wt of salivary IGF was similar to that of free plasma IGF after acid or neutral pH gel chromatography. Human saliva contained no significant IGF-binding protein. Eluates from neutral gel chromatography of concentrated (20-fold) normal saliva did not inhibit IGF-II binding to placental membrane receptors. Eluted proteins from saliva samples subjected to prior acid gel chromatography failed to bind radiolabeled IGF after neutralization. Saliva samples assayed for binding protein using an amniotic fluid binding protein RIA had values at or below the lower limit of detection [less than 0.06 micrograms eq/mL (mgeq/L)]. Salivary IGF-I concentrations did not change with increasing salivary flow rates above normal, with time of day, or with storage at room temperature for up to 24 h before freezing. The mean IGF-I concentration in mixed saliva from 14 normal young adults (8 men) was 2.3 +/- 0.3 (+/- SE) ng/mL (micrograms/L), and their mean plasma IGF-I level was 315 +/- 27 ng/mL (micrograms/L). Mean salivary IGF-I was significantly lower in 15 patients with GH deficiency [1.3 +/- 0.2 ng/mL (micrograms/L); P less than 0.01] and 8-fold higher in 5 acromegalic patients [17.2 +/- 6.3 ng/mL (micrograms/L); P less 0.01]. Removal of their GH adenomas led to a fall in salivary IGF-I to 5.6 +/- 1.3 ng/mL (micrograms/L); P less than 0.05). In summary, saliva contains free IGFs but no significant quantities of specific binding proteins. Salivary IGF-I levels reflect the GH status of the donor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360895     DOI: 10.1210/jcem-66-5-1014

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.

Authors:  Yasushi Adachi; Hirokazu Ohashi; Arisa Imsumran; Hiroyuki Yamamoto; Yasutaka Matsunaga; Hiroaki Taniguchi; Katsuhiko Nosho; Hiromu Suzuki; Yasushi Sasaki; Yoshiaki Arimura; David P Carbone; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Tumour Biol       Date:  2013-09-13

Review 2.  Pre-analytic considerations for the proper assessment of hormones of the hypothalamic-pituitary axis in epidemiological research.

Authors:  Rachel L Derr; Scott J Cameron; Sherita Hill Golden
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

3.  Serum insulin-like growth factor-1 levels in females and males in different cervical vertebral maturation stages.

Authors:  Shreya Gupta; Anuradha Deoskar; Puneet Gupta; Sandhya Jain
Journal:  Dental Press J Orthod       Date:  2015 Mar-Apr

4.  Effects of acute exercise on salivary free insulin-like growth factor 1 and interleukin 10 in sportsmen.

Authors:  Taye J Lasisi; Ade F Adeniyi
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

Review 5.  [Principles and clinical significance of insulin-like growth factors/somatomedins].

Authors:  E Weimann; W Kiess
Journal:  Klin Wochenschr       Date:  1990-10-17

6.  Novel roles of local insulin-like growth factor-1 activation in gastric ulcer healing: promotes actin polymerization, cell proliferation, re-epithelialization, and induces cyclooxygenase-2 in a phosphatidylinositol 3-kinase-dependent manner.

Authors:  Tom Nguyen; Jianyuan Chai; Aihua Li; Tomohiko Akahoshi; Tetsuya Tanigawa; Andrzej S Tarnawski
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

7.  Salivary free insulin-like growth factor-i levels: effects of an acute physical exercise in athletes.

Authors:  G Antonelli; R Gatti; M Prearo; E F De Palo
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

8.  Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma.

Authors:  Tiehong Zhang; Hongchang Shen; Wei Dong; Xiao Qu; Qi Liu; Jiajun Du
Journal:  Sci Rep       Date:  2014-10-31       Impact factor: 4.379

9.  Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study.

Authors:  Yasushi Adachi; Masanori Nojima; Mitsuru Mori; Kentaro Yamashita; Hiro-O Yamano; Hiroshi Nakase; Takao Endo; Kenji Wakai; Kiyomi Sakata; Akiko Tamakoshi
Journal:  World J Gastroenterol       Date:  2017-05-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.